======= SLC35A3 =======
== Gene Information ==
* **Official Symbol**: SLC35A3
* **Official Name**: solute carrier family 35 member A3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23443|23443]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y2D2|Q9Y2D2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SLC35A3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC35A3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605632|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a UDP-N-acetylglucosamine transporter found in the golgi apparatus membrane. In cattle, a missense mutation in this gene causes complex vertebral malformation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012].
* **UniProt Summary**: Uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) transporter in the Golgi apparatus. May supply UDP-GlcNAc as substrate for Golgi-resident glycosyltransferases that generate branching of diantennary oligosaccharides. {ECO:0000269|PubMed:10393322}.
|Nuc sug transp|
|UAA|
|UDP-N-acetylglucosamine transmembrane transporter activity|
|UDP-N-acetylglucosamine transmembrane transport|
|pyrimidine nucleotide-sugar transmembrane transport|
|nucleotide-sugar transmembrane transport|
|UDP-N-acetylglucosamine metabolic process|
|nucleotide-sugar metabolic process|
|amino sugar metabolic process|
|integral component of Golgi membrane|
|carbohydrate derivative transport|
|carbohydrate transport|
|nucleobase-containing compound transport|
|anion transmembrane transport|
|organic anion transport|
|nucleobase-containing small molecule metabolic process|
|anion transport|
|Golgi membrane|
|ion transmembrane transport|
|Golgi apparatus|
|carbohydrate derivative metabolic process|
|transmembrane transport|
|ion transport|
|small molecule metabolic process|
|nitrogen compound transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp22|MLN-4924 2μM R00 exp22]]|1.72|
|[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.81|
|[[:results:exp8|Brefeldin A 0.02μM R00 exp8]]|1.92|
|[[:results:exp50|Nicotinamide 2000μM R01 exp50]]|1.92|
|[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.94|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15421
* **Expression level (log2 read counts)**: 5.61
{{:chemogenomics:nalm6 dist.png?nolink |}}